Geode Capital Management LLC Purchases 55,934 Shares of Phreesia, Inc. (NYSE:PHR)

Geode Capital Management LLC boosted its position in Phreesia, Inc. (NYSE:PHR) by 4.7% during the third quarter, HoldingsChannel reports. The fund owned 1,245,797 shares of the company’s stock after buying an additional 55,934 shares during the quarter. Geode Capital Management LLC’s holdings in Phreesia were worth $28,397,000 as of its most recent filing with the SEC.

Several other institutional investors have also added to or reduced their stakes in the business. Champlain Investment Partners LLC lifted its stake in shares of Phreesia by 4.1% during the 3rd quarter. Champlain Investment Partners LLC now owns 2,503,837 shares of the company’s stock valued at $57,062,000 after buying an additional 97,847 shares in the last quarter. State Street Corp grew its stake in Phreesia by 7.1% in the 3rd quarter. State Street Corp now owns 1,327,586 shares of the company’s stock valued at $30,256,000 after buying an additional 88,517 shares in the last quarter. TimesSquare Capital Management LLC lifted its position in shares of Phreesia by 2.3% during the third quarter. TimesSquare Capital Management LLC now owns 868,409 shares of the company’s stock worth $19,791,000 after acquiring an additional 19,395 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its holdings in shares of Phreesia by 3.7% in the third quarter. Charles Schwab Investment Management Inc. now owns 447,239 shares of the company’s stock worth $10,193,000 after acquiring an additional 16,112 shares during the period. Finally, Squarepoint Ops LLC grew its position in shares of Phreesia by 56.3% in the second quarter. Squarepoint Ops LLC now owns 250,396 shares of the company’s stock valued at $5,308,000 after purchasing an additional 90,215 shares in the last quarter. 92.10% of the stock is owned by hedge funds and other institutional investors.

Phreesia Trading Up 2.3 %

PHR stock opened at $25.76 on Friday. Phreesia, Inc. has a one year low of $17.07 and a one year high of $29.16. The company has a market capitalization of $1.50 billion, a PE ratio of -17.52 and a beta of 0.98. The company’s 50 day moving average price is $21.18 and its two-hundred day moving average price is $22.12. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.77 and a current ratio of 1.74.

Phreesia (NYSE:PHR) last posted its quarterly earnings results on Monday, December 9th. The company reported ($0.25) earnings per share for the quarter, topping the consensus estimate of ($0.29) by $0.04. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The business had revenue of $106.80 million during the quarter, compared to the consensus estimate of $106.33 million. During the same period in the previous year, the firm posted ($0.58) earnings per share. The firm’s revenue for the quarter was up 16.6% on a year-over-year basis. As a group, analysts predict that Phreesia, Inc. will post -1.16 earnings per share for the current fiscal year.

Insider Activity at Phreesia

In other news, CEO Chaim Indig sold 3,089 shares of the business’s stock in a transaction that occurred on Tuesday, October 15th. The stock was sold at an average price of $21.03, for a total transaction of $64,961.67. Following the transaction, the chief executive officer now directly owns 1,220,647 shares of the company’s stock, valued at approximately $25,670,206.41. The trade was a 0.25 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, General Counsel Allison C. Hoffman sold 1,212 shares of the company’s stock in a transaction that occurred on Tuesday, October 15th. The shares were sold at an average price of $21.03, for a total value of $25,488.36. Following the transaction, the general counsel now owns 119,791 shares of the company’s stock, valued at approximately $2,519,204.73. This represents a 1.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 90,342 shares of company stock worth $2,041,225 in the last ninety days. 5.80% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on PHR. DA Davidson reaffirmed a “buy” rating and set a $32.00 target price on shares of Phreesia in a report on Thursday, September 5th. Needham & Company LLC reaffirmed a “buy” rating and set a $29.00 target price on shares of Phreesia in a report on Tuesday, December 10th. Robert W. Baird cut their price target on shares of Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a report on Wednesday, December 11th. JPMorgan Chase & Co. upped their price target on shares of Phreesia from $27.00 to $28.00 and gave the stock an “overweight” rating in a report on Monday, September 9th. Finally, Royal Bank of Canada reissued a “sector perform” rating and set a $23.00 price objective on shares of Phreesia in a research note on Friday, September 27th. One analyst has rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. According to MarketBeat.com, Phreesia currently has a consensus rating of “Moderate Buy” and an average price target of $29.33.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.